BRPI0815372A2 - marcador preditivo para o tratamento com inibidor do egfr - Google Patents
marcador preditivo para o tratamento com inibidor do egfrInfo
- Publication number
- BRPI0815372A2 BRPI0815372A2 BRPI0815372A BRPI0815372A BRPI0815372A2 BR PI0815372 A2 BRPI0815372 A2 BR PI0815372A2 BR PI0815372 A BRPI0815372 A BR PI0815372A BR PI0815372 A BRPI0815372 A BR PI0815372A BR PI0815372 A2 BRPI0815372 A2 BR PI0815372A2
- Authority
- BR
- Brazil
- Prior art keywords
- egfr inhibitor
- inhibitor treatment
- predictive marker
- predictive
- marker
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07114305 | 2007-08-14 | ||
| PCT/EP2008/006518 WO2009021679A1 (en) | 2007-08-14 | 2008-08-07 | Predictive marker for egfr inhibitor treamtent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0815372A2 true BRPI0815372A2 (pt) | 2019-09-24 |
Family
ID=39789783
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0815372A BRPI0815372A2 (pt) | 2007-08-14 | 2008-08-07 | marcador preditivo para o tratamento com inibidor do egfr |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP2176429A1 (de) |
| JP (1) | JP2010535520A (de) |
| KR (1) | KR20100037633A (de) |
| CN (1) | CN101802221A (de) |
| AU (1) | AU2008286412A1 (de) |
| BR (1) | BRPI0815372A2 (de) |
| CA (1) | CA2695318A1 (de) |
| MX (1) | MX2010001572A (de) |
| WO (1) | WO2009021679A1 (de) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5646249A (en) * | 1994-02-28 | 1997-07-08 | The United States Of America As Represented By The Department Of Health And Human Services | Isolation and characterization of a novel chaperone protein |
| WO2004111273A2 (en) * | 2003-05-30 | 2004-12-23 | Genomic Health, Inc. | Gene expression markers for response to egfr inhibitor drugs |
| EP2348110B1 (de) * | 2003-05-30 | 2013-03-27 | OncoTherapy Science, Inc. | Prozess zum screening einer medikamentenansprache in krebspatienten |
-
2008
- 2008-08-07 KR KR1020107003252A patent/KR20100037633A/ko not_active Application Discontinuation
- 2008-08-07 MX MX2010001572A patent/MX2010001572A/es not_active Application Discontinuation
- 2008-08-07 AU AU2008286412A patent/AU2008286412A1/en not_active Abandoned
- 2008-08-07 WO PCT/EP2008/006518 patent/WO2009021679A1/en active Application Filing
- 2008-08-07 CN CN200880102973A patent/CN101802221A/zh active Pending
- 2008-08-07 JP JP2010520467A patent/JP2010535520A/ja active Pending
- 2008-08-07 EP EP08785424A patent/EP2176429A1/de not_active Ceased
- 2008-08-07 BR BRPI0815372A patent/BRPI0815372A2/pt not_active IP Right Cessation
- 2008-08-07 CA CA2695318A patent/CA2695318A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009021679A1 (en) | 2009-02-19 |
| MX2010001572A (es) | 2010-03-15 |
| CA2695318A1 (en) | 2009-02-19 |
| JP2010535520A (ja) | 2010-11-25 |
| CN101802221A (zh) | 2010-08-11 |
| EP2176429A1 (de) | 2010-04-21 |
| AU2008286412A1 (en) | 2009-02-19 |
| KR20100037633A (ko) | 2010-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY2017016I1 (el) | Αναστολεις πρωτεασωματος | |
| BRPI0806898A2 (pt) | Inibidores de mek | |
| BRPI0813002A2 (pt) | marcadores preditivos para o câncer ovariano | |
| DK2041138T3 (da) | Pyrroltriazinkinase-inhibitorer | |
| DK2024375T3 (da) | Cyclopropyl-kondenserede indolobenzazepin-HCV-NS5B-hæmmere | |
| BRPI0821129A2 (pt) | Métodos para a inibição de cicatrização | |
| DK2066662T3 (da) | Serinhydrolaseinhibitorer | |
| BRPI0812040A2 (pt) | Indicações para terapia de anti-il-i-beta | |
| BRPI0815415A2 (pt) | Marcador preditivo para tratamento inibidor de egfr | |
| BRPI0815545A2 (pt) | Marcadores preditivos para o tratamento com inibidores de egfr | |
| ATE522533T1 (de) | Pyrazolopyrimidinonkinaseinhibitor | |
| ES1064044Y (es) | Plantilla para calzado | |
| BRPI0814257A2 (pt) | marcador preditivo para o tratamento do inibidor de egfr | |
| BRPI0814354A2 (pt) | Marcador preditivo para tratamento com inibidor de egfr | |
| BRPI0815414A2 (pt) | Marcador para o tratamento com inibidor de egfr | |
| BRPI0812105A2 (pt) | Neramexano para o tratamento de nistagmo | |
| BRPI0715729A2 (pt) | inibidores para glyt-1 | |
| BRPI0817361A2 (pt) | Marcador preditivo para tratamento com inibidor de egfr | |
| BRPI0815546A2 (pt) | Marcador preditivo para tratamento com inibidor da egfr | |
| ES2395881T9 (es) | Marcador predictivo para el tratamiento de inhibidor de EGFR | |
| BRPI0815372A2 (pt) | marcador preditivo para o tratamento com inibidor do egfr | |
| ES1064720Y (es) | Guia para persiana | |
| ES1064561Y (es) | Electrovalvula para grifo | |
| ES1063735Y (es) | Testero para persiana | |
| FI20075320A0 (fi) | Uusia käyttökelpoisia inhibiittoreita |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |